PINNACLE ASSOCIATES LTD - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$15,000
-99.2%
11,524
-99.1%
0.00%
-100.0%
Q2 2017$1,958,000
-53.6%
1,246,959
-4.6%
0.04%
-53.1%
Q1 2017$4,221,000
+133.9%
1,306,679
-2.3%
0.08%
+125.0%
Q4 2016$1,805,000
-15.0%
1,336,821
-1.8%
0.04%
-16.3%
Q3 2016$2,123,000
+9.1%
1,360,822
-7.0%
0.04%
+2.4%
Q2 2016$1,946,000
-74.9%
1,463,042
-0.5%
0.04%
-74.7%
Q1 2016$7,753,000
-32.1%
1,471,111
+1.2%
0.17%
-30.5%
Q4 2015$11,414,000
+0.4%
1,453,981
+8.0%
0.24%
-5.2%
Q3 2015$11,373,0001,345,9300.25%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,354,963$38,132,0001.80%
Orbimed Advisors 4,520,800$73,201,0001.55%
QVT Financial LP 1,326,610$21,480,0001.44%
BB BIOTECH AG 1,089,828$17,646,0001.27%
Meditor Group Ltd 250,000$4,048,0000.55%
Perimeter Capital Partners, LLC 159,915$2,589,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 156,808$2,539,0000.43%
Broadfin Capital, LLC 117,172$1,897,0000.37%
OXFORD ASSET MANAGEMENT LLP 811,331$13,184,0000.36%
Baker Brothers Advisors 1,016,433$16,458,0000.33%
View complete list of INFINITY PHARMACEUTICALS INC shareholders